BBBY Bull Ken Griffin’s 5 Favorite Stock Picks

2. Humana Inc. (NYSE:HUM)

Number of Hedge Fund Holders: 69 

Humana Inc. (NYSE:HUM) operates as a health and well-being firm. According to the latest data, Citadel owned 1.1 million shares of Humana Inc. (NYSE:HUM) at the end of the second quarter of 2022 worth $518 million, representing 0.13% of the portfolio. The company has been in the Citadel portfolio since the fourth quarter of 2010. 

On July 28, Oppenheimer analyst Michael Wiederhorn maintained an Outperform rating on Humana Inc. (NYSE:HUM) stock and increased the price target to $520 from $510, appreciating the second quarter earnings beat of the firm. 

At the end of the second quarter of 2022, 69 hedge funds in the database of Insider Monkey held stakes worth $3.7 billion in Humana Inc. (NYSE:HUM), up from 66 in the preceding quarter worth $3.1 billion. 

In its Q2 2022 investor letter, Oakmark Funds, an asset management firm, highlighted a few stocks and Humana Inc. (NYSE:HUM) was one of them. Here is what the fund said:

“During the quarter, we also sold our position in Humana Inc. (NYSE:HUM) in favor of names that, in our opinion, offer more potential upside. Geographically, we ended the quarter with 53% of the portfolio in the U.S., 38% in the U.K. and Europe, and 9% in Asia.”